These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours). Makimoto Y, Nabeshima K, Iwasaki H, Miyoshi T, Enatsu S, Shiraishi T, Iwasaki A, Shirakusa T, Kikuchi M. Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599 [Abstract] [Full Text] [Related]
4. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene. Sato K, Ueda Y, Shikata H, Katsuda S. Pathol Res Pract; 2006 Jun; 202(10):751-6. PubMed ID: 16959434 [Abstract] [Full Text] [Related]
5. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. Marchetti A, Pellegrini S, Bertacca G, Buttitta F, Gaeta P, Carnicelli V, Nardini V, Griseri P, Chella A, Angeletti CA, Bevilacqua G. J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374 [Abstract] [Full Text] [Related]
9. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung. Morandi L, Asioli S, Cavazza A, Pession A, Damiani S. Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687 [Abstract] [Full Text] [Related]
10. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Awaya H, Takeshima Y, Yamasaki M, Inai K. Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204 [Abstract] [Full Text] [Related]
15. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma. Haneda H, Sasaki H, Lindeman N, Kawano O, Endo K, Suzuki E, Shimizu S, Yukiue H, Kobayashi Y, Yano M, Fujii Y. Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241 [Abstract] [Full Text] [Related]
16. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity. Dacic S, Finkelstein SD, Yousem SA. Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439 [Abstract] [Full Text] [Related]
17. The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Barsky SH, Grossman DA, Ho J, Holmes EC. Mod Pathol; 1994 Aug; 7(6):633-40. PubMed ID: 7527541 [Abstract] [Full Text] [Related]
18. Immunohistopathological re-evaluation of adenocarcinoma of the lung with mixed subtypes using a tissue microarray technique and hierarchical clustering analysis. Gamal G, Sano T, Sakurai S, Kawashima O, Sugano M, Nakajima T. Pathol Int; 2007 Dec; 57(12):765-74. PubMed ID: 17988277 [Abstract] [Full Text] [Related]
19. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. Lung Cancer; 2004 Aug; 45(2):137-42. PubMed ID: 15246183 [Abstract] [Full Text] [Related]
20. Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient. Shinmura K, Suzuki M, Yamada H, Tao H, Goto M, Kamo T, Nagura K, Kageyama S, Kato M, Ogawa S, Maekawa M, Takamochi K, Suzuki K, Nakamura T, Sugimura H. Pathol Int; 2008 Nov; 58(11):706-12. PubMed ID: 18844936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]